07:06 AM EST, 02/27/2026 (MT Newswires) -- ANI Pharmaceuticals ( ANIP ) reported Q4 adjusted earnings Friday of $2.33 per diluted share, up from $1.63 a year earlier.

Analysts polled by FactSet expected $1.99

Revenue for the quarter ended Dec. 31 was $247.1 million, up from $190.6 million a year earlier.

Analysts surveyed by FactSet expected $231.1 million.

The company said it expects 2026 adjusted earnings of $8.83 to $9.34 per diluted share. Analysts surveyed by FactSet expect $8.76.

The company expects its 2026 revenue to be in the range of $1.06 billion to $1.12 billion. Analysts polled by FactSet expect $1.01 billion.

ANI Pharmaceuticals ( ANIP ) shares were up 7.6% in recent Friday pre-market activity.